BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3099116)

  • 21. Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.
    Schueler UH; Kolter T; Kaneski CR; Zirzow GC; Sandhoff K; Brady RO
    J Inherit Metab Dis; 2004; 27(5):649-58. PubMed ID: 15669681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.
    Prence EM; Chaturvedi P; Newburg DS
    J Neurosci Res; 1996 Feb; 43(3):365-71. PubMed ID: 8714525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
    Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
    FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
    J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of membrane-bound glucosylceramide: beta-glucosidase in fibroblasts cultured from normal and glucosylceramidotic human skin.
    Mueller OT; Rosenberg A
    J Biol Chem; 1979 May; 254(9):3521-5. PubMed ID: 429368
    [No Abstract]   [Full Text] [Related]  

  • 26. The synthetic pathway for glucosylsphingosine in cultured fibroblasts.
    Yamaguchi Y; Sasagasako N; Goto I; Kobayashi T
    J Biochem; 1994 Sep; 116(3):704-10. PubMed ID: 7852294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New aminocyclitols as modulators of glucosylceramide metabolism.
    Egido-Gabás M; Serrano P; Casas J; Llebaria A; Delgado A
    Org Biomol Chem; 2005 Apr; 3(7):1195-201. PubMed ID: 15785807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages.
    Das PK; Murray GJ; Gal AE; Barranger JA
    Exp Cell Res; 1987 Feb; 168(2):463-74. PubMed ID: 3803450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectors of three beta-glucosidases from human liver.
    Daniels LB; Gnarra JR; Glew RH
    Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants.
    Nilsson O; Grabowski GA; Ludman MD; Desnick RJ; Svennerholm L
    Clin Genet; 1985 May; 27(5):443-50. PubMed ID: 3924448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
    Walden CM; Sandhoff R; Chuang CC; Yildiz Y; Butters TD; Dwek RA; Platt FM; van der Spoel AC
    J Biol Chem; 2007 Nov; 282(45):32655-64. PubMed ID: 17848577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cytosolic beta-glucosidase in guinea pig liver cells.
    Hays WS; Wheeler DE; Eghtesad B; Glew RH; Johnston DE
    Hepatology; 1998 Jul; 28(1):156-63. PubMed ID: 9657108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB; Glew RH; Radin NS; Vunnam RR
    Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects.
    Stephens MC; Bernatsky A; Burachinsky V; Legler G; Kanfer JN
    J Neurochem; 1978 May; 30(5):1023-7. PubMed ID: 96213
    [No Abstract]   [Full Text] [Related]  

  • 35. Saposins (sphingolipid activator proteins) in the twitcher mutant mouse.
    Shigematsu H; Morimoto S; Kishimoto Y; Weiler S; Tomich J; Barranger J; Shinohara M; Yeager AM; O'Brien JS
    J Neurochem; 1990 Nov; 55(5):1659-62. PubMed ID: 2120388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of cerebrosides and sulfatides to saposins A-D.
    Soeda S; Hiraiwa M; O'Brien JS; Kishimoto Y
    J Biol Chem; 1993 Sep; 268(25):18519-23. PubMed ID: 8360153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors.
    Donsimoni R; Legler G; Bourbouze R; Lalegerie P
    Enzyme; 1988; 39(2):78-89. PubMed ID: 2969330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the possible identity of particulate beta-glucosidase and beta-xylosidase of mouse liver.
    Stephens MC; Bernatsky A; Legler G; Kanfer JN
    Biochim Biophys Acta; 1979 Nov; 571(1):70-8. PubMed ID: 40616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.
    Ridley CM; Thur KE; Shanahan J; Thillaiappan NB; Shen A; Uhl K; Walden CM; Rahim AA; Waddington SN; Platt FM; van der Spoel AC
    J Biol Chem; 2013 Sep; 288(36):26052-26066. PubMed ID: 23880767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice.
    Atsumi S; Nosaka C; Iinuma H; Umezawa K
    Arch Biochem Biophys; 1992 Sep; 297(2):362-7. PubMed ID: 1386724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.